Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Clinical trial NCT01499251 · TERMINATED
Trial details
- NCT number
- NCT01499251
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.